The scope and limitations for telepsychiatry after the COVID-19 pandemic was discussed in a recent correspondence to Irish Journal of Psychological Medicine (Hickey, Reference Hickey2021). The correspondence cited a paper by Kinoshita and colleagues to support that there is evidence indicating that service user adherence decreases when telemedicine is used for prolonged periods (Kinoshita et al., Reference Kinoshita, Cortright, Crawford, Mizuno, Yoshida and Hilty2020). In the discussion section of the paper by Kinoshita and colleagues, it is mentioned that there are reports that when telemedicine is used for long periods (several months to more than a year), patient adherence may decrease, and relevant references were cited by Kinoshita and colleages to support this in their paper. However it should be highlighted that the paper by Kinoshita and colleagues was a survey of telepsychiatry regulations, and the study which they conducted does not provide evidence supporting that the long-term use of telemedicine can decrease patient adherence.